Enrique Bernal-Morell

15PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceGene and molecular therapyImmunogenetics (incl. genetic immunology)Speech pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 24, 2026
Immune Trajectories After Switch to Long-Acting Cabotegravir Plus Rilpivirine in the RELATIVITY Cohort.

|Jun 10, 2026
Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023).

|Oct 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi

|Jul 25, 2025
Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023).

Juan Berenguer, Chiara Fanciulli, María M Arcos

|Jun 26, 2025
Evaluation of Insulin Resistance Markers for Diagnosing Moderate to Severe Hepatic Steatosis in Patients With Human Immunodeficiency Virus Using Transient Elastography.

Carlos Báguena, Cristina Tomás, Ángeles Muñoz

|May 14, 2025
Long-Term Health-Related Quality of Life in People Living with HIV Who Present to Care with AIDS or Severe Immunodeficiency: The CoRIS AIDS Survivors Study.

Julia Portilla-Tamarit, María José Fuster-RuizdeApodaca, Irene Portilla-Tamarit

Pageof 3

Frequent Collaborators

3 joint publications

Pere Domingo

3 joint publications

Jesús Troya

3 joint publications

Mar Masiá

3 joint publications

Jose Ramón Blanco